Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced late-breaking data demonstrating significant benefit of the DynamX(R) Coronary Bioadaptor System ...

Please provide your email address to receive an email when new articles are posted on . Registry data show transradial access was used for most patients who underwent complex, high-risk PCI.

Intracoronary imaging to guide complex PCI cases is initially more expensive than angiographic guidance but grows to be more cost-effective over a lifetime given the lower associated medical costs and ...

SAN FRANCISCO, CA—Among patients with complex coronary lesions, guiding PCI with either optical coherence tomography or intravascular ultrasound appears to yield similar results, according to a ...

A novel study shines a light on the physiological stress interventional cardiologists may encounter when performing complex percutaneous coronary intervention (PCI) procedures. The study of five ...

CVD remains the leading cause of death in the United States, with CAD being the most common cause of death attributable to CVD. Rates of CAD have been on the rise in the United States in conjunction ...

Washington, DC - ACUITY investigators have now published one-year results for the subset of ACS patients in the trial who subsequently underwent PCI [1]. This latest ACUITY paper suggests that there ...

The benefit of ticagrelor (Brilinta) monotherapy following a short course of dual antiplatelet therapy (DAPT) was upheld in various high-risk populations undergoing percutaneous coronary intervention ...